KMDA Q1 2023 Earnings — Kamada Ltd. Revenue & Financial Results | Market Cap Arena

KMDAKamada Ltd.

$520M

Q1 2023 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$31M+9.3% YoY

Gross Profit

$12M38.6% margin

Operating Income

$289,0000.9% margin

Net Income

-$2M-5.9% margin

EPS (Diluted)

$-0.04

QoQ Revenue Growth

-32.4%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$4M

Stock-Based Comp.

$415,000

Balance Sheet

Total Assets

$317M

Total Liabilities

$142M

Stockholders' Equity

$175M

Cash & Equivalents

$27M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$31M	$28M	+9.3%
Gross Profit	$12M	$11M	+4.8%
Operating Income	$289,000	$246,000	+17.5%
Net Income	-$2M	-$2M	+1.0%